Video

Dr. Shaughnessy Discusses Stem Cell Mobilization in Lymphomas

Paul J. Shaughnessy, MD, discusses stem cell mobilization in patients with lymphomas.

Paul J. Shaughnessy, MD, medical director of adult blood and marrow transplant at the Texas Transplant Institute, discusses stem cell mobilization in patients with lymphomas.

There are a variety of chemotherapy agents available to treat patients with different types of lymphoma, and physicians can still mobilize adequate stem cells, even with the newer chemotherapy regimens being used.

Physicians should also be aware of the risk of toxicity to underlining hematopoietic stem cells and not being able to collect adequate number of stem cells.

More studies are necessary, according to Shaughnessy, to better understand if enough stem cells are being given to patients and if this will impact patients better in the future.

<<< 2019 Transplantation and Cellular Therapy Meetings

Related Videos
Paolo Caimi, MD
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Benjamin P. Levy, MD, with Kristie Kahl and Andrew Svonavec
Binod Dhakal, MD
Jill Corre, PharmD, PhD
Saad Z. Usmani, MD, MBA, FACP, FASCO